AlloSource, a U.S. provider of allograft materials, has appointed Dean Elliott as the organization’s new President and CEO. Previously the company’s Chief Operating and Legal Officer, Mr. Elliott will assume his new leadership role in January 2023.
Elliott succeeds Tom Cycyota, who announced his retirement in August 2022 after leading the company for 22 years.
Elliott has been with AlloSource since 2003 and brings 30 years of legal, operational and leadership experience in the healthcare sector. Prior to joining AlloSource, Elliott served as the Director of Client Services for Eversana, and Acting General Manager of Staodyn.
“Dean’s passion for organ and tissue donation, his empathy, and his focus on operational excellence make him the ideal AlloSource President and CEO,” said Cycyota. “The selection of Mr. Elliott will continue the great things that AlloSource does each day with the gift of donated human tissue and will lead us to the next chapter of AlloSource’s success.”
AlloSource, a U.S. provider of allograft materials, has appointed Dean Elliott as the organization's new President and CEO. Previously the company's Chief Operating and Legal Officer, Mr. Elliott will assume his new leadership role in January 2023.
Elliott succeeds Tom Cycyota, who announced his retirement in August 2022 after leading the...
AlloSource, a U.S. provider of allograft materials, has appointed Dean Elliott as the organization’s new President and CEO. Previously the company’s Chief Operating and Legal Officer, Mr. Elliott will assume his new leadership role in January 2023.
Elliott succeeds Tom Cycyota, who announced his retirement in August 2022 after leading the company for 22 years.
Elliott has been with AlloSource since 2003 and brings 30 years of legal, operational and leadership experience in the healthcare sector. Prior to joining AlloSource, Elliott served as the Director of Client Services for Eversana, and Acting General Manager of Staodyn.
“Dean’s passion for organ and tissue donation, his empathy, and his focus on operational excellence make him the ideal AlloSource President and CEO,” said Cycyota. “The selection of Mr. Elliott will continue the great things that AlloSource does each day with the gift of donated human tissue and will lead us to the next chapter of AlloSource’s success.”
Copy to clipboard 
